Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of recombinant human brain natriuretic peptide in diabetes mellitus with heart failure
ChiCTR2500106611Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of nesiritide in Acute Heart Failure (AHF) and diabetes mellitus (DM) (2 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoint: NT-proBNP. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
nesiritide
03
Conditions
Acute Heart Failure (AHF)diabetes mellitus (DM)
Beyond the preview
Go deeper on ChiCTR2500106611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106611.